OptimizeRx (OPRX) Non-Current Deferred Tax Liability (2018 - 2026)

OptimizeRx (OPRX) has 9 years of Non-Current Deferred Tax Liability data on file, last reported at $5.7 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Deferred Tax Liability rose 49.37% year-over-year to $5.7 million; the trailing twelve-month figure through Mar 2026 stood at $5.7 million (up 49.37% YoY), and the FY2025 full-year result was $5.7 million, down 52.24% from the prior year.
• Non-Current Deferred Tax Liability eased to $5.7 million in Q1 2026, from $5.7 million in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $11.9 million in Q4 2024 to a low of $2.3 million in Q4 2022.
• A 5-year average of $4.8 million and a median of $4.3 million in 2023 frame the typical range for Non-Current Deferred Tax Liability.
• Across the five-year window, Non-Current Deferred Tax Liability surged 175.4% in 2024 and slumped 52.24% in 2025, its largest moves.
• Tracing OPRX's Non-Current Deferred Tax Liability over 5 years: stood at $2.3 million in 2022, then soared by 86.14% to $4.3 million in 2023, then surged by 175.4% to $11.9 million in 2024, then tumbled by 52.24% to $5.7 million in 2025, then decreased by 0.88% to $5.7 million in 2026.
• Business Quant data shows OPRX's Non-Current Deferred Tax Liability at $5.7 million in Q1 2026, $5.7 million in Q4 2025, and $4.5 million in Q3 2025.